Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
ARTICLE
Received29Dec2013|Accepted1Dec2014|Published23Jan2015
DOI:10.1038/ncomms6988
OPEN
Gd-metallofullerenolnanomaterialasnon-toxicbreastcancerstemcell-speci cinhibitor
YingLiu1,*,ChunyingChen1,*,PengxuQian2,*,XuefeiLu2,BaoyunSun1,XiaoZhang2,LimingWang1,
XingfaGao1,HanLi1,ZhiyunChen1,JinglongTang1,WeijieZhang2,JinquanDong1,RuBai1,PeterE.Lobie2,3,QingfaWu2,SulingLiu2,HuafengZhang2,FengZhao1,MaxS.Wicha4,TaoZhu2&YuliangZhao1
Thecontemporaryuseofnanomedicinesforcancertreatmenthasbeenlargelylimitedtoservingascarriersforexistingtherapeuticagents.Here,weprovidede nitiveevidencethat,themetallofullerenolnanomaterialGd@C82(OH)22,whileessentiallynottoxictonormalmammaryepithelialcells,possessesintrinsicinhibitoryactivityagainsttriple-negativebreastcancercells.Gd@C82(OH)22blocksepithelial-to-mesenchymaltransitionwithresultantef cienteliminationofbreastcancerstemcells(CSCs)resultinginabrogationoftumourinitiationandmetastasis.Innormoxicconditions,Gd@C82(OH)22mediatestheseeffectsbyblockingTGF-bsignalling.Moreover,underhypoxicconditionsfoundinthetumourmicro-environment,cellularuptakeofGd@C82(OH)22isfacilitatedwhereitfunctionsasabi-potentinhibitorofHIF-1aandTGF-bactivities,enhancingCSCelimination.ThesestudiesindicatethatnanomaterialscanbeengineeredtodirectlytargetCSCs.Thus,Gd-metallofullerenolisidenti edasakindofnon-toxicCSCspeci cinhibitorswithsigni canttherapeuticpotential.
1CASKeyLaboratoryforBiomedicalEffectsofNanomaterialsandNanosafety,NationalCenterforNanoscienceandTechnologyofChinaandInstituteofHigh
EnergyPhysics,ChineseAcademyofSciences(CAS),Beijing100190,China.2HefeiNationalLaboratoryforPhysicalSciencesatMicroscaleandSchoolofLifeSciences,UniversityofScienceandTechnologyofChina,Hefei,Anhui230027,China.3CancerScienceInstituteofSingaporeandDepartmentofPharmacology,NationalUniversityofSingapore,Singapore117456,Singapore.4ComprehensiveCancerCenter,DepartmentofInternalMedicine,UniversityofMichigan,AnnArbor,Michigan48109,USA.*Theseauthorscontributedequallytothiswork.CorrespondenceandrequestsformaterialsshouldbeaddressedtoT.Z.(email:zhut@ustc.edu.cn)ortoY.Z.(email:zhaoyuliang@ihep.ac.cn).
NATURECOMMUNICATIONS|6:5988|DOI:10.1038/ncomms6988|doc.guandang.net
1
Breast cancer stem-like cells and breast cancer therapy_专业资料。。 2 ? 4 主堡 壁 盘查 ! 皇至 生 旦箜鲞筮塑K BetiEemiEin,cbr00V1,o5n rsDsltn ...
The expression and significance of multi-drug resistance genes in breast cancer stem cells_专业资料。维普资讯 http://www.cqvip.com -。 xprs l e ehes...
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells_医学_高等教育_教育专区。介绍肿瘤干细胞与miRNA关系的文章...
Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells._基础医学_医药卫生_专业资料。ANTICANCER RESEARCH 33: 1873-1880 (2013) ...
The expression and significance of multi-drug resistance genes in breast cancer stem cells_专业资料。维普资讯 http://www.cqvip.com -。 xprs l e ehes...
热门文档